Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Treasury Shares (2019 - 2025)

Neurogene's Treasury Shares history spans 5 years, with the latest figure at $256361.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 1.68% year-over-year to $256361.0; the TTM value through Dec 2025 reached $256361.0, up 1.68%, while the annual FY2025 figure was $256361.0, 1.68% up from the prior year.
  • Treasury Shares reached $256361.0 in Q4 2025 per NGNE's latest filing, up from $252124.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $482384.0 in Q1 2024 to a low of $5750.0 in Q3 2023.
  • Average Treasury Shares over 3 years is $256677.5, with a median of $252124.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: skyrocketed 8206.31% in 2024, then plummeted 47.73% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $5750.0 in 2023, then soared by 4284.77% to $252124.0 in 2024, then rose by 1.68% to $256361.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Treasury Shares are $256361.0 (Q4 2025), $252124.0 (Q3 2025), and $271923.0 (Q2 2025).